Prognostic and predictive value of tumor-infiltrating lymphocytes in two phase III randomized adjuvant breast cancer trials
Author:
Funder
TRANSCAN JCT-2011g, French NCI
Publisher
Elsevier BV
Subject
Oncology,Hematology
Link
http://academic.oup.com/annonc/article-pdf/26/8/1698/16700087/mdv239.pdf
Reference14 articles.
1. Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy;Apetoh;Nat Med,2007
2. Development of tumor-infiltrating lymphocytes in breast cancer after neoadjuvant paclitaxel chemotherapy;Demaria;Clin Cancer Res,2001
3. In situ immune response after neoadjuvant chemotherapy for breast cancer predicts survival;Ladoire;J Pathol,2011
4. Tumor-associated lymphocytes as an independent predictor of response to neoadjuvant chemotherapy in breast cancer;Denkert;J Clin Oncol,2010
5. Prognostic and predictive value of tumor-infiltrating lymphocytes in a phase III randomized adjuvant breast cancer trial in node-positive breast cancer comparing the addition of docetaxel to doxorubicin with doxorubicin-based chemotherapy: BIG 02–98;Loi;J Clin Oncol,2013
Cited by 232 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Association of GATA3 expression in triple-positive breast cancer with overall survival and immune cell infiltration;Scientific Reports;2024-08-01
2. Targeting the tumor microenvironment to improve clinical outcomes in triple negative breast cancer patients and bridge the current disparity gap;Frontiers in Immunology;2024-07-12
3. High Caveolin-1 mRNA expression in triple-negative breast cancer is associated with an aggressive tumor microenvironment, chemoresistance, and poor clinical outcome;PLOS ONE;2024-07-03
4. Prediction value study of breast cancer tumor infiltrating lymphocyte levels based on ultrasound imaging radiomics;Frontiers in Oncology;2024-06-06
5. Optimizing Lymphocyte Detection in Breast Cancer Whole Slide Imaging Through Data-Centric Strategies;2024 IEEE International Symposium on Biomedical Imaging (ISBI);2024-05-27
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3